参考文献/References:
[1]Jia G,Whaley-connell A,Sowers JR.Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease[J].Diabetologia,2018,61(1):21-28.[2]Fontes-carvalho R,Ladeiras-lopes R,Bettencoutr P,et al.Diastolic dysfunction in the diabetic continuum: association with insulin resistance,metabolic syndrome and type 2 [J].Cardiovasc Diabetol,2015,14:4.[3]Katakami N.Mechanism of Development of Atherosclerosis and Cardiovascular Disease in Diabetes Mellitus [J].J Atheroscler Thromb,2018,25(1):27-39.[4]Liu JH,Wu MZ,Li SM,et al.Association of serum uric acid with biventricular myocardial dysfunction in patients with type 2 diabetes mellitus [J].Nutr Metab Cardiovasc Dis,2021,31(10):2912-2920.[5]Kunutsor SK,Kieneker LM,Bakker SJL,et al.Incident type 2 diabetes is associated with HDL,but not with its anti-oxidant constituent - paraoxonase-1:The prospective cohort PREVEND study [J].Metabolism,2017,73:43-51.[6]Bragg F,Kartsonaki C,Guo Y,et al.Circulating Metabolites and the Development of Type 2 Diabetes in Chinese Adults [J].Diabetes Care,2022,45(2):477-480.[7]Yang Y,Zhang J,Jia L,et al.Uric acid to high-density lipoprotein cholesterol ratio predicts adverse cardiovascular events in patients with coronary chronic total occlusion [J].Nutr Metab Cardiovasc Dis,2023,33(12):2471-2478.[8]Ko J,Kang HJ,Kim DA,et al.Uric acid induced the phenotype transition of vascular endothelial cells via induction of oxidative stress and glycocalyx shedding[J].FASEB J,2019,33(12):13334-13345.[9]Akyas G,Yilmaz S,Kantarci DB,et al.Is serum uric acid-to-HDL cholesterol ratio elevation associated with diabetic kidney injury?[J].Postgrad Med,2023,135(5):519-523.[10]Akyas G,Khalid A,Kurtkuiagi O,et al.Poorly controlled hypertension is associated with elevated serum uric acid to HDL-cholesterol ratio: a cross-sectional cohort study[J].Postgrad Med,2022,134(3):297-302.[11]Yazdi F,Baghaei MH,Baniasad A,et al.Investigating the relationship between serum uric acid to high-density lipoprotein ratio and metabolic syndrome[J].Endocrinol Diabetes Metab,2022,5(1):e00311.[12]Mikami T,Sorimachi M.Uric acid contributes greatly to hepatic antioxidant capacity besides protein[J].Physiol Res,2017,66(6):1001-1007.[13]Chida R,Hisauchi I,Toyoda S,et al.Impact of irbesartan, an angiotensin receptor blocker, on uric acid level and oxidative stress in high-risk hypertension patients[J].Hypertens Res,2015,38(11):765-769.[14]Xiong Q,Liu J,Xu Y.Effects of Uric Acid on Diabetes Mellitus and Its Chronic Complications[J].Int J Endocrinol,2019,2019:9691345.[15]Lee-rueckkert M,Blanco-vaca F,Kovanen PT,et al.The role of the gut in reverse cholesterol transport--focus on the enterocyte[J].Prog Lipid Res,2013,52(3):317-328.[16]诸骏仁,高润霖,赵水平,等.中国成人血脂异常防治指南(2016年修订版)[J].中国循环杂志,2016,31(10):937-953.[17]Kosekli MA,Kurtkulagii O,Kahvecl G,et al.The association between serum uric acid to high density lipoprotein-cholesterol ratio and non-alcoholic fatty liver disease: the abund study [J].Rev Assoc Med Bras(1992),2021,67(4):549-554.[18]Kocak MZ,Aktas G,Erkus E,et al.Serum uric acid to HDL-cholesterol ratio is a strong predictor of metabolic syndrome in type 2 diabetes mellitus[J].Rev Assoc Med Bras (1992),2019,65(1):9-15.[19]Liu R,Peng Y,Wu H,et al.Uric acid to high-density lipoprotein cholesterol ratio predicts cardiovascular mortality in patients on peritoneal dialysis[J].Nutr Metab Cardiovasc Dis,2021,31(2):561-569.[20]尤玉青,李伟,周东浩.血尿酸/高密度脂蛋白胆固醇比值与糖尿病肾脏疾病的相关性研究[J].中国糖尿病杂志,2021,29(10):749-753.[21]陈张哲,葛丹,凌宏威,等.血尿酸/高密度脂蛋白胆固醇比值预测新诊断2型糖尿病患者胰岛素抵抗价值的研究[J].中国糖尿病杂志,2023,31(4):246-250.[22]Wang H,Ba Y,Gao X,et al.Association between serum uric acid to high density lipoprotein-cholesterol ratio and arterial stiffness in a Japanese population[J].Medicine (Baltimore),2023,102(31):e34182.[23]Jean G,Van Mieghem NM,Gegenava T,et al.Moderate Aortic Stenosis in Patients With Heart Failure and Reduced Ejection Fraction[J].J Am Coll Cardiol,2021,77(22):2796-2803.
相似文献/References:
[1]黄德斌,章臻翊,章 婷,等.2型糖尿病患者亚临床甲状腺功能减退与白蛋白尿的关系研究[J].医学信息,2018,31(02):88.[doi:10.3969/j.issn.1006-1959.2018.02.030]
HUANG De-bin,ZHANG Zhen-yi,ZHANG Ting,et al.Relationship between Subclinical Hypothyroidism and Albuminuria in
Patients with Type 2 Diabetes Mellitus[J].Journal of Medical Information,2018,31(17):88.[doi:10.3969/j.issn.1006-1959.2018.02.030]
[2]邓婷婷,王亚洲,张 红.口福怡稻治疗2型糖尿病的临床效果研究[J].医学信息,2018,31(03):116.[doi:10.3969/j.issn.1006-1959.2018.03.039]
DENG Ting-ting,WANG Ya-zhou,ZHANG Hong.Clinical Study on the Treatment of Type 2 Diabetes Mellitus with Kou Fuyi Dao[J].Journal of Medical Information,2018,31(17):116.[doi:10.3969/j.issn.1006-1959.2018.03.039]
[3]曹岚,侯瑞田,王福慧,等.Lp-PLA2血小板相关因子与2型糖尿病合并高血压病的
相关性研究[J].医学信息,2018,31(05):3.[doi:10.3969/j.issn.1006-1959.2018.05.002]
CAO Lan,HOU Rui-tian,WANG Fu-hui,et al.Study on the Correlation between Lp-PLA2 Platelet-associated Factors and Type 2 Diabetes Mellitus Complicated with Hypertension[J].Journal of Medical Information,2018,31(17):3.[doi:10.3969/j.issn.1006-1959.2018.05.002]
[4]靳雪芹,邓正聪.代谢综合征与肿瘤关系的研究进展[J].医学信息,2018,31(05):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
JIN Xue-qin,DENG Zheng-cong.Research Progress on the Relationship between Metabolic Syndrome and Tumor[J].Journal of Medical Information,2018,31(17):35.[doi:10.3969/j.issn.1006-1959.2018.05.014]
[5]刘 洪.地特胰岛素或甘精胰岛素联合使用口服药物治疗2型糖尿病疗效及对体重的影响分析[J].医学信息,2018,31(09):135.[doi:10.3969/j.issn.1006-1959.2018.09.042]
LIU Hong.Effect of Insulin Detemir or Insulin Glargine Combined with Oral Medication on Type 2 Diabetes Mellitus and its Influence on Body Weight[J].Journal of Medical Information,2018,31(17):135.[doi:10.3969/j.issn.1006-1959.2018.09.042]
[6]刘静波,黄 萍,赵 静.应用微信平台对初发中青年2型糖尿病患者进行
健康管理模式的研究[J].医学信息,2018,31(14):98.[doi:10.3969/j.issn.1006-1959.2018.14.028]
LIU Jing-bo,HUANG Ping,ZHAO Jing.Study on the Health Management Model of Young and Middle-aged Patients with Type 2 Diabetes Mellitus by WeChat Platform[J].Journal of Medical Information,2018,31(17):98.[doi:10.3969/j.issn.1006-1959.2018.14.028]
[7]丁 星,赵 畅,张海严,等.麦邦数据远程传输型血糖仪临床测量准确性的评价研究[J].医学信息,2018,31(15):64.[doi:10.3969/j.issn.1006-1959.2018.15.020]
DING Xing,ZHAO Chang,ZHANG Hai-yan,et al.Evaluation of Accuracy of Clinical Measurement of Maibang Remote Data Transmission Glucometer[J].Journal of Medical Information,2018,31(17):64.[doi:10.3969/j.issn.1006-1959.2018.15.020]
[8]梁延洋,程艳娜,华柏慧,等.胃癌合并2型糖尿病术后血糖改善的临床观察[J].医学信息,2018,31(17):187.[doi:10.3969/j.issn.1006-1959.2018.17.061]
LIANG Yan-yang,CHENG Yan-na,HUA Bai-hui,et al.Clinical Observation of Postoperative Blood Glucose Improvement in Patients with Gastric Cancer Complicated with Type 2 Diabetes Mellitus[J].Journal of Medical Information,2018,31(17):187.[doi:10.3969/j.issn.1006-1959.2018.17.061]
[9]刘小红.长效胰岛素联合口服降糖药治疗2型糖尿病的
疗效与安全性评价[J].医学信息,2018,31(18):121.[doi:10.3969/j.issn.1006-1959.2018.18.038]
LIU Xiao-hong.Efficacy and Safety of Long Acting Insulin Combined with Oral Hypoglycemic Agents in Treatment of Type 2 Diabetes Mellitus[J].Journal of Medical Information,2018,31(17):121.[doi:10.3969/j.issn.1006-1959.2018.18.038]
[10]鲍 哲,杨升伟,柯赛赛,等.益生元对2型糖尿病患者糖脂代谢的影响[J].医学信息,2018,31(18):132.[doi:10.3969/j.issn.1006-1959.2018.18.042]
BAO Zhe,YANG Sheng-wei,KE Sai-sai,et al.Effect of Prebiotics on Glucose and Lipid Metabolism in Patients with Type 2 Diabetes mellitus[J].Journal of Medical Information,2018,31(17):132.[doi:10.3969/j.issn.1006-1959.2018.18.042]